Prognostic value of sarcopenia in survivors of hematological malignances undergoing a hematopoietic stem cell transplantation: a systematic review and meta-analysis.
Shuli JiaRunjuan QiaoYuting XiaoDan QinWanyu ZhaoYunli ZhaoXiaolei LiuBirong DongPublished in: Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer (2020)
Clinicians could use sarcopenia to balance the risks and benefits of transplantation as early as possible; in addition, interventions can be used to prevent sarcopenia and improve physical function and quality of life. Well-designed, prospective, and large-scale clinical studies are needed to consolidate the evidence.